HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$4.40
Day range
$4.25 - $4.57
Year range
$2.38 - $11.99
Market cap
46.16M USD
Avg Volume
82.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.73M | 33.73% |
Net income | -5.44M | -40.67% |
Net profit margin | — | — |
Earnings per share | -0.51 | -41.67% |
EBITDA | -5.73M | -33.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 38.36M | -25.58% |
Total assets | 39.73M | -28.42% |
Total liabilities | 3.97M | 35.28% |
Total equity | 35.77M | — |
Shares outstanding | 10.76M | — |
Price to book | 1.33 | — |
Return on assets | -34.37% | — |
Return on capital | -37.17% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -5.44M | -40.67% |
Cash from operations | -3.07M | 18.33% |
Cash from investing | -556.17K | 42.12% |
Cash from financing | 54.72K | — |
Net change in cash | -3.58M | 24.21% |
Free cash flow | -1.21M | 52.06% |
About
Founded
2013
Headquarters
Website
Employees
21